258 related articles for article (PubMed ID: 23613008)
1. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
[TBL] [Abstract][Full Text] [Related]
2. White matter damage, neuroinflammation, and neuronal integrity in HAND.
Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
[TBL] [Abstract][Full Text] [Related]
3. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
[TBL] [Abstract][Full Text] [Related]
4. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
[TBL] [Abstract][Full Text] [Related]
5. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
6. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
7. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
9. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
[TBL] [Abstract][Full Text] [Related]
10. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
12. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
Mohamed MA; Barker PB; Skolasky RL; Selnes OA; Moxley RT; Pomper MG; Sacktor NC
Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
[TBL] [Abstract][Full Text] [Related]
13. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
Yiannoutsos CT; Nakas CT; Navia BA;
Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
[TBL] [Abstract][Full Text] [Related]
14. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
[TBL] [Abstract][Full Text] [Related]
15. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA;
Clin Infect Dis; 2010 Mar; 50(6):920-9. PubMed ID: 20146627
[TBL] [Abstract][Full Text] [Related]
16. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
[TBL] [Abstract][Full Text] [Related]
17. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
[TBL] [Abstract][Full Text] [Related]
18. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
[TBL] [Abstract][Full Text] [Related]
20. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
